Specialist MDT: Barts Health NHS Trust
View Provider Services
Men diagnosed at this hospital trust can access the following services:
- Diagnostic Facilities:
- Multiparametric MRI
- Transperineal biopsy under local anaesthetic
- Transperineal biopsy under general anaesthetic
- Transrectal ultrasound (TRUS) biopsy
- Choline PET
- PSMA (prostate-specific membrane antigen) PET scan
- Isotope bone scan
- Treatment Facilities:
- External beam radiotherapy (EBRT)
- Stereotactic body radiation therapy (SBRT)
- Chemotherapy
- Joint specialist MDT clinic
- Support Service Facilities:
- Clinical Nurse Specialist (CNS) in all clinics
- Prostate cancer-specific CNSs
- Advanced PCa CNS
- Urology CNS
- Sexual function services
- Specialist continence services
- Psychological counselling
Data Quality
For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021.
This is the data completeness of the National Cancer Registration Dataset (NCRD).
For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.
| Diagnosing Trust | Specialist MDT | |
|---|---|---|
| No. of Cancer Registry records | 406 | 545 |
| Performance Status recorded | 0% | 0% |
| PSA completed | 33% | 49% |
| Gleason Score completed | 68% | 69% |
| TNM completed | 67% | 73% |
Disease Presentation
For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.
| Specialist MDT | National | |
|---|---|---|
| No. of men with disease status determined | 478 | 39897 |
| Percentage of men diagnosed with metastatic disease | 15% | 17% |
Management
For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.